Preliminary studies suggest conolidine could inhibit specific ion channels, lowering neuronal excitability and limiting agony signals. This mechanism is especially pertinent in neuropathic agony, where abnormal signaling causes persistent discomfort. Additionally, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to suf